SpyBiotech, a life sciences spinout from the U.K.’s Oxford University, has raised £4 million ($ 5 million) in seed funding from Oxford Sciences Innovation (OSI) and Alphabet’s investment arm GV (formerly Google Ventures). As traditional approaches to developing vaccines are typically time-consuming, and not always effective, SpyBiotech is working on what it calls a “proprietary protein […]
